McKune John 4
4 · Pulmonx Corp · Filed Mar 5, 2024
Insider Transaction Report
Form 4
Pulmonx CorpLUNG
McKune John
Interim CFO
Transactions
- Sale
Common Stock
2024-03-01$9.06/sh−155$1,404→ 48,333 total - Sale
Common Stock
2024-03-01$9.06/sh−254$2,301→ 48,079 total - Sale
Common Stock
2024-03-01$9.06/sh−669$6,061→ 47,410 total - Award
Common Stock
2024-03-01+14,400→ 61,810 total - Award
Employee Stock Option (right to buy)
2024-03-01+28,800→ 28,800 totalExercise: $9.30Exp: 2034-02-28→ Common Stock (28,800 underlying)
Footnotes (6)
- [F1]These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on June 1, 2021.
- [F2]Includes 841 shares acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan on February 21, 2024.
- [F3]These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2022.
- [F4]These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023.
- [F5]Represents grant of RSUs payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on March 1, 2024.
- [F6]The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2024.